Repository of samples for cerebrovascular disorders
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
This study is collecting blood, fluid, and tissue samples from people with cerebrovascular diseases and strokes to help researchers learn more about these conditions and how to improve treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 900 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT02910180 on ClinicalTrials.gov |
What this trial studies
This study involves the creation and maintenance of a repository of biological samples from patients with cerebrovascular diseases and strokes. It collects various types of samples, including blood, cerebrospinal fluid, and tissue, to facilitate future analyses. The goal is to better categorize patients, understand the underlying causes of these conditions, and identify biomarkers associated with patient outcomes. This prospective observational approach aims to enhance knowledge about the natural progression of cerebrovascular diseases and the effects of treatments.
Who should consider this trial
Good fit: Ideal candidates for this study include all patients diagnosed with cerebrovascular disease, regardless of age, gender, or treatment stage.
Not a fit: Patients who are pregnant will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment of cerebrovascular diseases, potentially enhancing patient outcomes.
How similar studies have performed: Other studies have successfully utilized biological sample repositories to advance understanding of cerebrovascular diseases, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients diagnosed with cerebral vascular disease, regardless of gender, age, ethnicity/race, stage of disease or treatment, are eligible. * Expected availability of clinical follow up data * Participants must be willing to provide written, informed consent obtained in accordance with institutional and federal guidelines. Exclusion Criteria: * Pregnant women are excluded from the study.
Where this trial is running
Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Nestor R Gonzalez, MD, MSCR — Cedars-Sinai Neurosurgery
- Study coordinator: Nestor R Gonzalez, MD, MSCR
- Email: Nestor.Gonzalez@cshs.org
- Phone: (310) 423-0783
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.